ReviewSeminars in thrombosis and hemostasis2020
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
Review in Seminars in thrombosis and hemostasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Molecular docking of polyphenol compounds and exploring the anticoagulant activity ofToxicology reports · 2025Article
- Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy.Hematology reports · 2024Article
- Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke.Frontiers of medicine · 2023Review
- The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on ischemic stroke and the possible underlying mechanisms.The International journal of neuroscience · 2023Article
- Clinical Outcomes of Anticoagulant Therapy in COVID-19 Patients with Pre-Existing Cardiovascular Diseases: A Systematic Review.Infection and drug resistance · 2023Review
- The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia.Thrombosis journal · 2022Article
- Does COVID-19 infection increase the risk of pressure injury in critically ill patients?: A narrative review.Medicine · 2022Review
- COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases.Cardiology discovery · 2021Article
- Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study.Journal of clinical medicine · 2021Article
- The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19.International journal of laboratory hematology · 2021Review
- Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.International journal of laboratory hematology · 2021Review
- Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.Medicine · 2021Article
- Modulation of Hemostasis in COVID-19; Blood Platelets May Be Important Pieces in the COVID-19 Puzzle.Pathogens (Basel, Switzerland) · 2021Review
- How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn.Life (Basel, Switzerland) · 2021Review
- Management of COVID-19-associated coagulopathy in persons with haemophilia.Haemophilia : the official journal of the World Federation of Hemophilia · 2021Article
- COVID-19: The crucial role of blood coagulation and fibrinolysis.Internal and emergency medicine · 2020Article
- Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.Pharmacotherapy · 2020Review
- Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.Seminars in thrombosis and hemostasis · 2020Review
- Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19).Seminars in thrombosis and hemostasis · 2020Review
- Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis.Clinica chimica acta; international journal of clinical chemistry · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.